Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine

Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518.

Posted: 18 Aug 2020

See all articles by Mateo Aboy

Mateo Aboy

LML, University of Cambridge

Cristina Crespo

University of Cambridge

Kathleen Liddell

University of Cambridge - Faculty of Law

Timo Minssen

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law

John Liddicoat

University of Cambridge - Faculty of Law; University of Tasmania

Date Written: May 3, 2019

Abstract

On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals.

Suggested Citation

Aboy, Mateo and Crespo, Cristina and Liddell, Kathleen and Minssen, Timo and Liddicoat, Johnathon, Mayo’s Impact on Patent Applications Related to Biotechnology, Diagnostics and Personalized Medicine (May 3, 2019). Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine. / Aboy, Mateo; Crespo, Cristina; Liddell, Kathleen; Minssen, Timo; Liddicoat, Johnathan, Nature Biotechnology, Vol. 37, 05.2019, p. 513-518., Available at SSRN: https://ssrn.com/abstract=3653112

Mateo Aboy

LML, University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

HOME PAGE: http://https://www.lml.law.cam.ac.uk/people/Research-Scholars-Associates/Prof-mateo-aboy

Cristina Crespo

University of Cambridge ( email )

Trinity Ln
Cambridge, CB2 1TN
United Kingdom

Kathleen Liddell

University of Cambridge - Faculty of Law ( email )

10 West Road
Cambridge, CB3 9DZ
United Kingdom

Timo Minssen (Contact Author)

University of Copenhagen - Centre for Advanced Studies in Biomedical Innovation Law (CeBIL) - Faculty of Law ( email )

Karen Blixens Plads 16
Copenhagen, 2300
Denmark
+46 708 607517 (Phone)

HOME PAGE: http://jura.ku.dk/cebil/staff/profile/?pure=en/persons/381631

Johnathon Liddicoat

University of Cambridge - Faculty of Law ( email )

10 West Road
Cambridge, CB3 9DZ
United Kingdom

University of Tasmania ( email )

French Street
Sandy Bay
Hobart, Tasmania 7001
Australia

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
39
PlumX Metrics